文献速递肝病

综述:肝脂肪变及其与急慢性肝病的关联

Review article: Hepatic steatosis and its associations with acute and chronic liver diseases.
PubMed 文献 · Aliment Pharmacol Ther · 2024-06-07

本文综述肝脂肪变的组织病理学与发生机制及其与常见和罕见疾病的关联。肝脂肪变多为大泡性,小泡性脂肪变与急性线粒体功能障碍和肝衰竭相关。MASLD是最重要的相关肝病,脂滴生成与动态复杂,需进一步研究。

要点

  • 肝脂肪变是MASLD的标志,全球患病率上升。
  • 小泡性脂肪变与急性线粒体功能障碍和肝衰竭相关。
  • 脂滴生成与动态复杂,需进一步研究。

核心结论

  • 多种肝病与肝脂肪变相关,MASLD是最重要的贡献者。
  • 肝细胞脂滴的生成与动态复杂,需进一步研究。
  • 细胞器界面允许脂质代谢共同调节,使潜在毒性脂质种类生成与其脂滴储存相匹配。

研究设计与样本

  • 综述:通过PubMed数据库检索脂滴生物学基础科学及与肝脂肪变相关的急慢性肝病临床研究文献。

主要发现

  • 多种遗传和环境因素促成慢性肝脂肪变或脂肪性肝病,通常表现为大泡性。
  • 小泡性脂肪变与急性线粒体功能障碍和肝衰竭相关。
  • 肝细胞中导致脂肪变的脂肪代谢过程包括脂蛋白颗粒分泌、残余脂蛋白颗粒或游离脂肪酸摄取、从头脂肪生成、脂肪酸氧化、脂解和脂噬。
  • 肝脏胰岛素抵抗是MASLD的关键特征。
  • Seipin是一种促进脂滴生成的多功能蛋白,丙型肝炎病毒组装发生在脂滴表面,脂滴与内质网及其他细胞器有重要功能性接触。

局限性

  • 肝细胞脂滴的生成与动态复杂,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatic steatosis is a common finding in liver histopathology and the hallmark of metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), whose global prevalence is rising. AIMS: To review the histopathology of hepatic steatosis and its mechanisms of development and to identify common and rare disease associations. METHODS: We reviewed literature on the basic science of lipid droplet (LD) biology and clinical research on acute and chronic liver diseases associated with hepatic steatosis using the PubMed database. RESULTS: A variety of genetic and environmental factors contribute to the development of chronic hepatic steatosis or steatotic liver disease, which typically appears macrovesicular. Microvesicular steatosis is associated with acute mitochondrial dysfunction and liver failure. Fat metabolic processes in hepatocytes whose dysregulation leads to the development of steatosis include secretion of lipoprotein particles, uptake of remnant lipoprotein particles or free fatty acids from blood, de novo lipogenesis, oxidation of fatty acids, lipolysis and lipophagy. Hepatic insulin resistance is a key feature of MASLD. Seipin is a polyfunctional protein that facilitates LD biogenesis. Assembly of hepatitis C virus takes place on LD surfaces. LDs make important, functional contact with the endoplasmic reticulum and other organelles. CONCLUSIONS: Diverse liver pathologies are associated with hepatic steatosis, with MASLD being the most important contributor. The biogenesis and dynamics of LDs in hepatocytes are complex and warrant further investigation. Organellar interfaces permit co-regulation of lipid metabolism to match generation of potentially toxic lipid species with their LD depot storage.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Koenig AB, Tan A, Abdelaal H, et al. Review article: Hepatic steatosis and its associations with acute and chronic liver diseases. Aliment Pharmacol Ther. 2024. PMID: 38845486. doi:10.1111/apt.18059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。